Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

First Edition

Review Article February 19 2025
Implementing ASH's Guidelines for Acute Medical Care for Children and Adults with Sickle Cell Disease in Custody
Research Article February 19 2025
Presentation of CXCL12γ by heparan sulfate proteoglycans activates CXCR4 without desensitization in B cells
Letter February 19 2025
ATM inhibition decreases ERK activation and is synergistic with ibrutinib in primary chronic lymphocytic leukemia cells
Research Article February 19 2025
Improved Outcome and Therapeutic Directions in Pediatric Therapy-related AML: Recommendations by the AML-BFM Study Group
Letter February 19 2025
Long-Term Outcomes and Quality of Life with Treosulfan-Based Conditioning in Hematological Malignancies
Letter February 19 2025
Assessing AML-based risk criteria in patients with accelerated/blast-phase MPN treated with less-intensive therapy
Research Article February 14 2025
Characterizing the heterogeneity of Castleman disease and oligocentric subtype: Findings from the ACCELERATE registry
Research Article February 14 2025
Phase 1 trial of durvalumab (anti-PD-L1) combined with lenalidomide in relapsed/refractory cutaneous T cell lymphoma
Review Article February 14 2025
Fedratinib in 2025 and Beyond: Indications and Future Applications
Research Article February 14 2025
In Vitro Studies of Human Erythropoiesis Using a 3D Silk-Based Bone Marrow Model That Generates Erythroblastic Islands
Research Article February 12 2025
Late-Onset Telomere Biology Disorders: Clinical Insights and Treatment Outcomes from a Retrospective Registry Cohort
Research Article February 12 2025
Mitigating T-Cell Mitochondrial Dysfunction in CLL to Augment CAR T-Cell Therapy: Evaluation in an Immunocompetent Model
Research Article February 12 2025
Persistent post-remission clonal hematopoiesis shapes the relapse trajectories of acute myeloid leukemia
Letter February 12 2025
The Differential Expression of Circulating MicroRNAs in Sickle Cell Trait compared to the Normal Hemoglobin Phenotype.
Letter February 12 2025
Prior Exposure to Belantamab Mafodotin Influences Outcomes with Idecabtagene Vicluecel in Patients with Multiple Myeloma
Research Article February 10 2025
Protection of CD33-modified hematopoietic stem cell progeny from CD33-directed CAR T cells in nonhuman primates
Research Article February 10 2025
Single-cell dynamics of breakthrough toxicities following anakinra prophylaxis for axicabtagene ciloleucel in lymphoma
Research Article February 10 2025
Post Transplant Cyclophosphamide as GvHD Prophylaxis in Patients Receiving Mismatched Unrelated HCT: the PHYLOS trial.
Research Article February 10 2025
Randomized Phase II Study to Assess the Role of Single-Agent Nivolumab to Maintain Remission in Acute Myeloid Leukemia
Research Article February 10 2025
Cellular and biochemical heterogeneity contributes to the phenotypic diversity of transfusion-dependent beta thalassemia
Research Article February 6 2025
C3 as a predictive and prognostic biomarker in adult hemophagocytic lymphohistiocytosis: a large cohort study in China
Research Article February 6 2025
Metabolically Aberrant Extracellular Mitochondria Induce Oxidative Endotheliopathy in Traumatic Brain Injury
Review Article February 6 2025
Diagnosis, management, and outcomes of drug-induced erythrocytosis: A systematic review.
Research Article February 6 2025
Acute obstetric coagulopathy is associated with excess plasmin generation and proteolysis of fibrinogen and factor V
Review Article February 6 2025
FITNESS ASSESSMENT IN ACUTE MYELOID LEUKEMIA: RECOMMENDATIONS FROM AN EXPERT PANEL ON BEHALF OF EUROPEAN LEUKEMIA NET
Letter February 6 2025
A Novel Mouse Model to Study the Effects of New Therapies for Diamond Blackfan Anemia
Letter February 6 2025
GVHD in the era of checkpoint inhibition in Hodgkin Lymphoma
Letter February 5 2025
Targeting RNA Modification and Mitochondrial Metabolism Crosstalk in Leukemic Stem Cells with CDK7 Inhibitor TGN-1062
Research Article February 5 2025
Phase II trial of ibrutinib and nivolumab in patients with relapsed CNS lymphomas
Letter February 5 2025
Supernumerary ring chromosome 1 syndrome leads to fusion-driven B-cell Acute Lymphoblastic Leukemia in monozygotic twins
Research Article February 5 2025
Mosunetuzumab plus Pola-CHP compared with Pola-R-CHP in previously untreated DLBCL: final results from a Phase II study
Research Article February 5 2025
Allogeneic Off-the-Shelf CAR T-Cell Therapy for Relapsed or Refractory B-Cell Malignancies
Research Article February 5 2025
Factors associated with early quality of life response to palliative care during hematopoietic cell transplantation
Research Article February 5 2025
Intermediate-Dose Post-Transplantation Cyclophosphamide for Myeloablative HLA-Haploidentical Bone Marrow Transplantation
Research Article February 5 2025
Differential antibody response to EBV proteome following EBVST immunotherapy in EBV-associated lymphomas
Letter February 5 2025
What to do with the WEIGHT while preparing for CAR-T?
Research Article February 5 2025
Glucagon-Like Peptide 1 Receptor Agonists and Venous Thromboembolism in Type 2 Diabetes: A Target Trial Emulation
Letter February 5 2025
Immune-aging is linked to clinical malignancy, racial ancestry and vaccine responses in myeloma
Letter February 4 2025
ICE polychemotherapy is an efficient salvage treatment in relapsed/refractory primary central nervous system lymphoma.
Research Article February 4 2025
Pre-Transplant MRD Does Not Seem to Impact Survival in NPM1-Mutated AML Undergoing Allogeneic Stem Cell Transplantation
Research Article February 4 2025
CD19.CAR-T cell-derived extracellular vesicles express CAR and kill leukemic cells, contributing to antineoplastic therapy
Letter February 4 2025
Desensitization to calaspargase pegol appears to be less successful than pegaspargase
Letter February 4 2025
Estimating rare genetic disease prevalence: a challenging task
Letter February 4 2025
Distress and Symptom Burden in Patients with Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma
Review Article January 30 2025
Solitary Plasmacytoma: Single institution experience and systematic review and meta-analysis of clinical outcomes
Research Article January 30 2025
Impact of Vein-to-vein Time in Patients With R/R LBCL Treated With Axicabtagene Ciloleucel
Research Article January 30 2025
Six-month Rituximab-Lenalidomide regimen in advanced untreated Follicular Lymphoma: SAKK 35/10 Trial 10-year Update
Research Article January 30 2025
A Model of Zymogen Factor XII: Insights into Protease Activation
Research Article January 28 2025
Deciphering the complex clonal heterogeneity of polycythemia vera and the response to interferon alpha
Research Article January 28 2025
Outcome of high-grade B-cell lymphoma compared to other large B-cell lymphoma after CAR-T rescue. A DESCAR-T LYSA study
Page 1 of 3
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals